Oligonucleotide Synthesis Market - North America is expected to remain dominant during 2021 to 2030

The global oligonucleotide synthesis market was valued at $51.97 billion in 2020 and is projected to reach $ 26.099 billion by 2030 registering a CAGR of 17.1% from 2021 to 2030.

• 𝐂𝐀𝐆𝐑: 17.1%
• 𝐂𝐮𝐫𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞: 𝐔𝐒𝐃 51.97 𝐁𝐢𝐥𝐥𝐢𝐨𝐧
• 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐑𝐞𝐠𝐢𝐨𝐧: 𝐀𝐏𝐀𝐂
• 𝐋𝐚𝐫𝐠𝐞𝐬𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚
• 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧 𝐓𝐢𝐦𝐞: 2021- 2030
• 𝐁𝐚𝐬𝐞 𝐘𝐞𝐚𝐫: 2021

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐇𝐞𝐫𝐞 : https://www.alliedmarketresearch.com/request-sample/8721

The oligonucleotide synthesis market can be analyzed regionally to understand the market dynamics, growth opportunities, and key players operating in specific geographical areas. Here is a regional analysis of the oligonucleotide synthesis market:

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚:
The North American region, particularly the United States, has a well-established biotechnology and pharmaceutical industry, driving the demand for oligonucleotide synthesis.

The presence of major market players, research institutions, and academic centers focused on genomics and personalized medicine contributes to market growth.

Increased investment in research and development activities, coupled with government initiatives promoting genomics research, fuels the market growth in this region.

𝐄𝐮𝐫𝐨𝐩𝐞:
Europe has a significant presence in the oligonucleotide synthesis market, with countries such as Germany, the United Kingdom, France, and Switzerland leading in research and development.
The European market benefits from advancements in genomics, personalized medicine, and gene therapy, leading to increased demand for custom oligonucleotides.

The presence of prominent pharmaceutical companies, academic institutes, and government support for research and development contributes to market growth.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (243 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/oligonucleotide-synthesis-market/purchase-options

𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜:
The Asia Pacific region is experiencing rapid growth in the oligonucleotide synthesis market due to factors such as increasing healthcare expenditure, rising demand for precision medicine, and growing biotechnology and pharmaceutical sectors.
Countries like China, Japan, South Korea, and India are major contributors to market growth in this region, driven by advancements in genomics research, rising population, and increasing awareness about personalized medicine.

The presence of contract research organizations (CROs) offering oligonucleotide synthesis services and favorable government policies promoting biotechnology research and development further support market growth.

𝐋𝐚𝐭𝐢𝐧 𝐀𝐦𝐞𝐫𝐢𝐜𝐚:
Latin America is witnessing steady growth in the oligonucleotide synthesis market, primarily driven by the increasing adoption of molecular diagnostics, growing focus on precision medicine, and advancements in genomics research.
Brazil, Mexico, and Argentina are key countries contributing to the growth of the market in this region.

Collaborations between academic institutes, research organizations, and industry players, along with government initiatives supporting biotechnology and genomics research, are fueling market growth.

𝐌𝐢𝐝𝐝𝐥𝐞 𝐄𝐚𝐬𝐭 𝐚𝐧𝐝 𝐀𝐟𝐫𝐢𝐜𝐚:
The oligonucleotide synthesis market in the Middle East and Africa is relatively smaller compared to other regions but is witnessing gradual growth.
Factors such as increasing investments in healthcare infrastructure, rising awareness about genomics-based diagnostics and therapeutics, and growing collaborations with global market players are driving market expansion in this region.
Countries like South Africa, Saudi Arabia, and the United Arab Emirates are the key contributors to market growth.

𝐅𝐨𝐫 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐢𝐧𝐪𝐮𝐢𝐫𝐢𝐞𝐬: https://www.alliedmarketresearch.com/purchase-enquiry/8721

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
Based on product, the oligonucleotide-based drugs held the largest share in the global market in 2020.

On the basis of application, the therapeutic application held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.

By end user, the hospitals segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.

Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 16.00% during the forecast period.

𝐎𝐥𝐢𝐠𝐨𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 -
• Thermo Fisher Scientific Inc.,
• Merck KGaA,
• Eurofins Scientific,
• LGC Limited,
• Danaher Corporation,
• Integrated DNA Technologies, Inc.

𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞 -https://www.alliedmarketresearch.com/oligonucleotide-synthesis-market-A08356

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧 -
𝐑𝐚𝐫𝐞 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 𝐒𝐩𝐞𝐜𝐢𝐦𝐞𝐧 𝐂𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐒𝐭𝐚𝐛𝐢𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.alliedmarketresearch.com/rare-biomarkers-specimen-collection-and-stabilization-market-A13226

𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐌𝐲𝐞𝐥𝐨𝐦𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/multiple-myeloma-market

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐄𝐱𝐨𝐬𝐤𝐞𝐥𝐞𝐭𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/medical-exoskeleton-market-A11183

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.